Genome-Wide A → G and C → T Mutations Induced by Functional TadA Variants in .

ACS Synth Biol

Laboratory of Synthetic Microbiology, School of Chemical Engineering & Technology, Tianjin University, Tianjin 300072, P. R. China.

Published: February 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The fusion expression of deoxyribonucleic acid (DNA) replication-related proteins with nucleotide deaminase enzymes promotes random mutations in bacterial genomes, thereby increasing genetic diversity among the population. Most previous studies have focused on cytosine deaminase, which produces only C → T mutations, significantly limiting the variety of mutation types. In this study, we developed a fusion expression system by combining DnaG (RNA primase) with adenine deaminase TadA-8e (DnaG-TadA) in , which is capable of rapidly introducing A → G mutations into the genome, resulting in a 664-fold increase in terms of mutation rate. Additionally, we tested a dual-functional TadA variant, TadAD, and then fused it with DnaG. This construct introduced both C → T and A → G mutations into the genome, with the mutation rate increased by 370-fold upon coexpression with a uracil glycosylase inhibitor (DnaG-TadAD-UGI). We applied DnaG-TadA and DnaG-TadAD-UGI systems to the adaptive laboratory evolution for Cd and kanamycin resistance, achieving an 8.0 mM Cd and 200 μg/mL kanamycin tolerance within just 17 days and 132 h, respectively. Compared to conventional evolution methods, the final tolerance levels were increased by 320 and 266%, respectively. Our work offers a novel strategy for random mutagenesis in and potentially other prokaryotic species.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acssynbio.4c00597DOI Listing

Publication Analysis

Top Keywords

→ mutations
16
→ →
8
fusion expression
8
mutations genome
8
mutation rate
8
5
mutations
5
genome-wide →
4
mutations induced
4
induced functional
4

Similar Publications

Off-white or yellowish shoots are common in tea plants ( L.), and such albino variations are often accompanied by metabolic reprogramming, including increased contents of amino acids and lower levels of polyphenols. Nonetheless, the molecular mechanisms that underlie these albino variations remain to be fully clarified.

View Article and Find Full Text PDF

Plants produce diverse and abundant natural products that are critical for plant adaptation and human society. While tremendous diversification of plant natural product pathways is well documented, how the upstream primary metabolism evolved in coordination with lineage-specific pathways remains poorly understood. Here, we studied the evolution of aromatic amino acid (AAA) biosynthesis during the emergence of the tyrosine-derived lignin pathway uniquely found in grasses and closely related Poales.

View Article and Find Full Text PDF

Cell cycle progression relies on coordinated signaling systems that integrate diverse cellular and environmental cues. In and related Alphaproteobacteria, the essential sensor histidine kinase CckA initiates a phosphorelay signaling cascade that controls both the transcriptional activity and proteolytic stability of the master cell cycle regulator, CtrA. To uncover regulatory connections between this essential signaling pathway and other cellular processes, we selected for mutations that bypassed the loss of CckA function.

View Article and Find Full Text PDF

Background: In the phase 3 CodeBreaK 300 study, sotorasib (KRAS inhibitor) plus panitumumab (EGFR inhibitor) significantly prolonged progression-free survival versus investigator's choice of trifluridine-tipiracil or regorafenib (standard of care) in patients with KRAS-mutated chemorefractory metastatic colorectal cancer. This analysis evaluated patient-reported outcomes (PROs) as secondary and exploratory endpoints.

Methods: In this open-label, randomised clinical trial, adult (aged ≥18 years) patients from 67 centres in 13 countries in Asia, Australia, Europe, and North America with KRAS-mutated chemorefractory metastatic colorectal cancer (as assessed by central molecular testing of tumour biopsy specimens) who were KRAS inhibitor-naive, had progressed to recurrence after previous therapy with fluoropyrimidine, oxaliplatin, and irinotecan, with measurable disease according to the Response Evaluation Criteria in Solid Tumors version 1.

View Article and Find Full Text PDF

Spastic Paraplegia 4 (SPG4) is the most prevalent form of Hereditary Spastic Paraplegia (HSP), a neurodegenerative disorder characterized by progressive lower limb spasticity and debilitating gait impairment, primarily driven by axonal degeneration of corticospinal motor neurons (CSMNs). Caused by mutations in the gene encoding spastin, an AAA-ATPase involved in microtubule severing and intracellular organelle function, SPG4 accounts for 40-50% of autosomal dominant HSP cases, yet without effective treatments. Although reduced microtubule acetylation has emerged as a key pathological mechanism, whether and how distinct mutations lead to microtubule deacetylation and subsequent neurodegeneration remains unclear.

View Article and Find Full Text PDF